User:Mr. Ibrahem/Tiagabine
Clinical data | |
---|---|
Pronunciation | /taɪˈæɡəbiːn/ |
Trade names | Gabitril |
AHFS/Drugs.com | Monograph |
MedlinePlus | a698014 |
Pregnancy category |
|
Routes of administration | By mouth (tablets) |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 90–95%[1] |
Protein binding | 96%[1] |
Metabolism | Liver (CYP450 system,[1] primarily CYP3A)[3] |
Elimination half-life | 5–8 hours[2] |
Excretion | Fecal (63%) and kidney (25%)[3] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C20H25NO2S2 |
Molar mass | 375.55 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Tiagabine, sold under the brand name Gabitril, is a medication primarily used to treat epilepsy.[4] Specifically it is used for partial seizure that are not controllable by other measures.[4] Use for other disorders is discouraged.[4] It is taken by mouth, usually with food in divided doses over the day, starting at a small dose and increased gradually.[6]
Common side effects include tiredness, sleepiness, nausea, irritability, pain, and trouble sleeping.[4] In certain types of epilepsy, it may increase seizure frequency.[5] Other side effects may include suicide and Stevens-Johnson syndrome.[4] While safety in pregnancy is unclear, there are concerns it may harm the baby.[4] It is believed to work by affecting γ-aminobutyric acid (GABA).[4]
Tiagabine was approved for medical use in the United States in 1997.[4] In the United Kingdom 100 tablets of 10 mg costs the NHS about £104 as of 2021.[5] This amount in the United States costs about 300 USD.[7][8]
References[edit]
- ^ a b c Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 562–. ISBN 978-1-60913-345-0. Archived from the original on 29 August 2021. Retrieved 13 January 2021.
- ^ Brodie, Martin J. (1995). "Tiagabine Pharmacology in Profile". Epilepsia. 36 (s6): S7–S9. doi:10.1111/j.1528-1157.1995.tb06015.x. ISSN 0013-9580. PMID 8595791. S2CID 27336198.
- ^ a b "Gabitril (tiagabine hydrochloride) Tablets. U.S. Full Prescribing Information" (PDF). Cephalon, Inc. Archived (PDF) from the original on 2 April 2016. Retrieved 8 April 2016.
- ^ a b c d e f g h i j "TiaGABine Monograph for Professionals". Drugs.com. Archived from the original on 19 January 2021. Retrieved 3 October 2021.
- ^ a b c BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 348. ISBN 978-0-85711-369-6.
{{cite book}}
: CS1 maint: date format (link) - ^ Rogawski, Michael A. (2020). "24. Antiseizure drugs". In Katzung, Bertram G.; Trevor, Anthony J. (eds.). Basic and Clinical Pharmacology (15th ed.). New York: McGraw-Hill. p. 434. ISBN 978-1-260-45231-0. Archived from the original on 2021-10-10. Retrieved 2021-11-08.
- ^ "TiaGABine Monograph for Professionals". Drugs.com. Archived from the original on 19 January 2021. Retrieved 3 October 2021.
- ^ "Gabitril Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 5 May 2016. Retrieved 4 October 2021.